These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9391679)
21. [Anaphylactoid reactions to an injectable solution of a cremophor-containing solution of multivitamins]. Mounier P; Laroche D; Divanon F; Mosquet B; Vergnaud MC; Esse-Comlan A; Piquet MA; Bricard H Therapie; 1995; 50(6):571-3. PubMed ID: 8745958 [TBL] [Abstract][Full Text] [Related]
22. Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients. van Tellingen O; Huizing MT; Panday VR; Schellens JH; Nooijen WJ; Beijnen JH Br J Cancer; 1999 Sep; 81(2):330-5. PubMed ID: 10496361 [TBL] [Abstract][Full Text] [Related]
23. Oxidative capacities of cardiac and skeletal muscles of heart transplant recipients: mitochondrial effects of cyclosporin-A and its vehicle Cremophor-EL. N' Guessan BB; Sanchez H; Zoll J; Ribera F; Dufour S; Lampert E; Kindo M; Geny B; Ventura-Clapier R; Mettauer B Fundam Clin Pharmacol; 2014 Apr; 28(2):151-60. PubMed ID: 23046032 [TBL] [Abstract][Full Text] [Related]
24. Effects of Cremophor EL on distribution of Taxol to serum lipoproteins. Sykes E; Woodburn K; Decker D; Kessel D Br J Cancer; 1994 Sep; 70(3):401-4. PubMed ID: 7915910 [TBL] [Abstract][Full Text] [Related]
25. Well-tolerated oral cyclosporine in a case of hypersensitivity to parenteral cyclosporine in postallogeneic bone marrow transplantation. Moeinian M; Sotoude H; Mohebbi Z; Asadollahi-Amin A; Mozafari R Indian J Pharmacol; 2018; 50(2):94-96. PubMed ID: 30100659 [TBL] [Abstract][Full Text] [Related]
26. Leaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous cyclosporine solution. Venkataramanan R; Burckart GJ; Ptachcinski RJ; Blaha R; Logue LW; Bahnson A; Giam CS; Brady JE Am J Hosp Pharm; 1986 Nov; 43(11):2800-2. PubMed ID: 3799618 [TBL] [Abstract][Full Text] [Related]
27. Effect of unpurified Cremophor EL on the solution stability of paclitaxel. Gogate US; Schwartz PA; Agharkar SN Pharm Dev Technol; 2009; 14(1):1-8. PubMed ID: 18791935 [TBL] [Abstract][Full Text] [Related]
28. Phase I trial of cremophor EL with bolus doxorubicin. Millward MJ; Webster LK; Rischin D; Stokes KH; Toner GC; Bishop JF; Olver IN; Linahan BM; Linsenmeyer ME; Woodcock DM Clin Cancer Res; 1998 Oct; 4(10):2321-9. PubMed ID: 9796961 [TBL] [Abstract][Full Text] [Related]
29. In vitro hemolysis and buffer capacity studies with the novel marine anticancer agent kahalalide F and its reconstitution vehicle cremophor EL/ethanol. Nuijen B; Bouma M; Manada C; Jimeno JM; Bult A; Beijnen JH PDA J Pharm Sci Technol; 2001; 55(4):223-9. PubMed ID: 11505554 [TBL] [Abstract][Full Text] [Related]
30. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling. van den Bongard HJ; Mathôt RA; van Tellingen O; Schellens JH; Beijnen JH Cancer Chemother Pharmacol; 2002 Jul; 50(1):16-24. PubMed ID: 12111107 [TBL] [Abstract][Full Text] [Related]
31. The effects of cremophor EL in the anaesthetized dog. Gaudy JH; Sicard JF; Lhoste F; Boitier JF Can J Anaesth; 1987 Mar; 34(2):122-9. PubMed ID: 3829297 [TBL] [Abstract][Full Text] [Related]
32. Effect of paclitaxel and Cremophor EL on mast cell histamine secretion and their interaction with adriamycin. Decorti G; Bartoli Klugmann F; Candussio L; Baldini L Anticancer Res; 1996; 16(1):317-20. PubMed ID: 8615628 [TBL] [Abstract][Full Text] [Related]
33. Phase I study of taxol administered as a short i.v. infusion daily for 5 days. Grem JL; Tutsch KD; Simon KJ; Alberti DB; Willson JK; Tormey DC; Swaminathan S; Trump DL Cancer Treat Rep; 1987 Dec; 71(12):1179-84. PubMed ID: 2891442 [TBL] [Abstract][Full Text] [Related]
34. Pharmacologic sensitivity of paclitaxel to its delivery vehicles drives distinct clinical outcomes of paclitaxel formulations. Li Y; Chen N; Palmisano M; Zhou S Mol Pharm; 2015 Apr; 12(4):1308-17. PubMed ID: 25714793 [TBL] [Abstract][Full Text] [Related]
35. Cremophor EL augments the cytotoxicity of hydrogen peroxide in lymphocytes dissociated from rat thymus glands. Iwase K; Oyama Y; Tatsuishi T; Yamaguchi JY; Nishimura Y; Kanada A; Kobayashi M; Maemura Y; Ishida S; Okano Y Toxicol Lett; 2004 Dec; 154(1-2):143-8. PubMed ID: 15475188 [TBL] [Abstract][Full Text] [Related]
36. Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut. Bardelmeijer HA; Ouwehand M; Malingré MM; Schellens J; Beijnen JH; van Tellingen O Cancer Chemother Pharmacol; 2002 Feb; 49(2):119-25. PubMed ID: 11862425 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80. Ellis AG; Crinis NA; Webster LK Cancer Chemother Pharmacol; 1996; 38(1):81-7. PubMed ID: 8603456 [TBL] [Abstract][Full Text] [Related]
38. Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review. Volcheck GW; Van Dellen RG Ann Allergy Asthma Immunol; 1998 Feb; 80(2):159-63. PubMed ID: 9494448 [TBL] [Abstract][Full Text] [Related]
39. Cremophor EL Nano-Emulsion Monomerizes Chlorophyll Janik-Zabrotowicz E; Arczewska M; Zubik M; Terpilowski K; Skrzypek TH; Swietlicka I; Gagos M Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31888249 [TBL] [Abstract][Full Text] [Related]
40. Effects of paclitaxel with or without cremophor EL on cellular clonogenic survival and apoptosis. Engblom P; Pulkkinen JO; Rantanen V; Hirvonen H; Kulmala J; Grènman R; Grènman S Eur J Cancer; 1999 Feb; 35(2):284-8. PubMed ID: 10448272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]